Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zimmer Biomet Holdings (ZBH)

Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,669,564
  • Shares Outstanding, K 198,182
  • Annual Sales, $ 8,232 M
  • Annual Income, $ 705,000 K
  • EBIT $ 1,764 M
  • EBITDA $ 2,858 M
  • 60-Month Beta 0.62
  • Price/Sales 2.37
  • Price/Cash Flow 7.07
  • Price/Book 1.52

Options Overview Details

View History
  • Implied Volatility 27.17% (+1.36%)
  • Historical Volatility 24.36%
  • IV Percentile 47%
  • IV Rank 22.73%
  • IV High 48.79% on 04/08/25
  • IV Low 20.82% on 08/12/25
  • Expected Move (DTE 28) 5.34 (5.38%)
  • Put/Call Vol Ratio 0.41
  • Today's Volume 246
  • Volume Avg (30-Day) 936
  • Put/Call OI Ratio 2.29
  • Today's Open Interest 23,408
  • Open Int (30-Day) 17,422
  • Expected Range 93.91 to 104.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.86
  • Number of Estimates 11
  • High Estimate 1.91
  • Low Estimate 1.83
  • Prior Year 1.81
  • Growth Rate Est. (year over year) +2.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.59 +17.33%
on 01/29/26
99.57 -0.32%
on 02/19/26
+11.94 (+13.68%)
since 01/16/26
3-Month
84.59 +17.33%
on 01/29/26
99.57 -0.32%
on 02/19/26
+9.80 (+10.96%)
since 11/19/25
52-Week
84.59 +17.33%
on 01/29/26
114.44 -13.27%
on 04/03/25
-4.09 (-3.96%)
since 02/19/25

Most Recent Stories

More News
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

ZBH : 99.25 (+1.02%)
3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

3 Reasons to Avoid ZBH and 1 Stock to Buy Instead

ZBH : 99.25 (+1.02%)
ZBH Investor Alert: Hagens Berman Investigates Zimmer Biomet (ZBH) Over Alleged Emerging Market Failures and "Inconsistent" Execution

Partner Reed Kathrein Scrutinizing ZBH's "High Confidence" Assurances After 15% Stock Collapse and Reduced Revenue Guidance

ZBH : 99.25 (+1.02%)
The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call

The Top 5 Analyst Questions From Zimmer Biomet’s Q4 Earnings Call

ZBH : 99.25 (+1.02%)
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month.

ZBH : 99.25 (+1.02%)
EW : 78.92 (-0.08%)
AZN : 205.64 (-1.43%)
Zimmer Biomet Stock: Is Wall Street Bullish or Bearish?

Zimmer Biomet has trailed the broader market over the past year, and it continues to face skeptical sentiment from analysts regarding its near- to medium-term growth outlook.

ZBH : 99.25 (+1.02%)
$SPX : 6,861.89 (-0.28%)
IHI : 59.12 (-0.56%)
ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum

ZBH Q4 Deep Dive: U.S. Salesforce Overhaul Drives Guidance Caution Amid Product Momentum

ZBH : 99.25 (+1.02%)
Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations

Zimmer Biomet (NYSE:ZBH) Beats Q4 CY2025 Sales Expectations

ZBH : 99.25 (+1.02%)
Zimmer: Q4 Earnings Snapshot

Zimmer: Q4 Earnings Snapshot

ZBH : 99.25 (+1.02%)
Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results

WARSAW, Ind. , Feb. 10, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2025.  The Company reported...

ZBH : 99.25 (+1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products....

See More

Key Turning Points

3rd Resistance Point 101.92
2nd Resistance Point 100.74
1st Resistance Point 100.00
Last Price 99.25
1st Support Level 98.08
2nd Support Level 96.90
3rd Support Level 96.16

See More

52-Week High 114.44
Fibonacci 61.8% 103.04
Fibonacci 50% 99.51
Last Price 99.25
Fibonacci 38.2% 95.99
52-Week Low 84.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar